Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2200 participants.
Also called NCT02334969
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 2,200 participants
- Sponsor
- Xiaofei Yu
- Registry
-
NCT02334969
-
- Other papers using this trial's data
- Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02334969. Randomized; double masking; primary purpose prevention. Start 2016-04 (actual); primary completion 2018-08-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Naoxintong Capsule
- Intervention (Drug)
- Placebo
- Lead sponsor
- Xiaofei Yu
- Collaborator
- Shanghai Municipal Science and Technology Commission
Record details
- Record id
cardio:ct-nct02334969- Content hash
de7a906b120409eba8a66d7c2639164f0470acac34aca7e5a1247b977d098ee6